Vima LLC
INDV icon

Vima LLC’s Indivior Pharmaceuticals INDV Stock Holding History

Vima LLC’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.6K Hold
603
– – 0.02% 209
2026
Q2 		$24.7K Buy
+603
New +$21.9K 0.02% 204
2024
Q1 		– Sell
-50
Closed -$764 – 473
2023
Q4 		$764 Buy
+50
New +$888 ﹤0.01% 362

Other funds holding INDV

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Vima LLC's INDV Position: Q3 2026 in Review

Vima LLC held its Indivior Pharmaceuticals (INDV) position steady in Q3 2026 at 603 shares worth $21.6K. The position accounts for 0.02% of the portfolio, ranked #209.

Vima LLC first reported a position in INDV in Q4 2023 and has held it in 3 quarters since. The position peaked at $24.7K in Q2 2026. 80 funds tracked by Wall St. Rank hold INDV as of Q3 2026.

  • Vima LLC held 603 shares of Indivior Pharmaceuticals worth $21.6K as of Q3 2026.
  • Vima LLC left its Indivior Pharmaceuticals share count unchanged in Q3 2026.
  • Indivior Pharmaceuticals made up 0.02% of Vima LLC's portfolio in Q3 2026, its #209 holding.
  • Vima LLC first reported a position in Indivior Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
  • Vima LLC's Indivior Pharmaceuticals position peaked at $24.7K in Q2 2026.
  • 80 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2026.

Based on Vima LLC's 13F filing for Q3 2026, filed 23 Oct 2026.